Product * Biosimilar Ph2 not performed Commercialization preparation Product Process Development Preclinical Phase 1 Phase 2 Phase 3 Marketing Note Recombinant Hyaluronidase (Hybrozyme™) Tergase® Commercialization in Korea Approved by MFDS in 2024
